You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AIDS Vaccines

Showing 51 - 75 of 4,451
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Boston, New York (ALVAC(2)120(B,MN)GNP (vCP1452), Keyhole-Limpet Hemocyanin)

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • Keyhole-Limpet Hemocyanin
  • Boston, Massachusetts
  • +1 more
Oct 28, 2021

HIV Trial in United States (APL 400-047, ALVAC-HIV MN120TMG (vCP205), Sargramostim)

Completed
  • HIV Infections
  • APL 400-047
  • +2 more
  • Birmingham, Alabama
  • +3 more
Oct 28, 2021

HIV Trial (GEO-D03 DNA Vaccine, MVA/HIV62B Vaccine, Placebo for DNA GEO-D03)

Withdrawn
  • HIV Infections
  • GEO-D03 DNA Vaccine
  • +3 more
  • (no location specified)
Nov 4, 2021

HIV Trial in United States (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • +2 more
  • Birmingham, Alabama
  • +5 more
Oct 28, 2021

HIV Trial in Saint Louis, Pittsburgh (gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • gp160 Vaccine (MicroGeneSys)
  • Saint Louis, Missouri
  • +1 more
Oct 27, 2021

HIV Trial in United States (TBC-3B Vaccine, Smallpox Vaccine)

Completed
  • HIV Infections
  • TBC-3B Vaccine
  • Smallpox Vaccine
  • Saint Louis, Missouri
  • +4 more
Oct 27, 2021

Influenza Trial in Baltimore (H5N1 pISV)

Completed
  • Influenza
  • H5N1 pISV
  • Baltimore, Maryland
    Center for Immunization Research, Johns Hopkins Bloomberg School
Feb 15, 2022

HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, MN rgp120/HIV-1 and A244 rgp120/HIV-1, ALVAC-HIV MN120TMG

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
  • +3 more
  • Birmingham, Alabama
  • +17 more
Oct 27, 2021

HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and A244 rgp120/HIV-1
  • +2 more
  • Baltimore, Maryland
  • +3 more
Oct 28, 2021

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +4 more
Oct 28, 2021

HIV Trial in Baltimore, Saint Louis (gp160 Vaccine (Immuno-AG), Hepatitis B Vaccine (Recombinant))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Hepatitis B Vaccine (Recombinant)
  • Baltimore, Maryland
  • +1 more
Oct 26, 2021

HIV Trial in Birmingham, Saint Louis, Rochester (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • +2 more
  • Birmingham, Alabama
  • +2 more
Oct 28, 2021

Rheumatic Disease, HIV, AIDS Trial in São Paulo (CoronaVac)

Active, not recruiting
  • Rheumatic Disease
  • +5 more
  • CoronaVac
  • São Paulo, SP, Brazil
    University of Sao Paulo General Hospital
May 24, 2022

HIV Trial in United States (gp160 Vaccine (Immuno-AG), gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • gp160 Vaccine (MicroGeneSys)
  • Palo Alto, California
  • +3 more
Oct 27, 2021

HIV Trial in Switzerland, United States (DNA Nat-B env, DNA CON-S env, DNA Mosaic env)

Completed
  • HIV Infections
  • DNA Nat-B env
  • +7 more
  • Birmingham, Alabama
  • +6 more
Oct 13, 2021

HIV Trial in United States (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • +2 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

HIV Infection Trial in South Africa (ALVAC-HIV, Bivalent Subtype C gp120/MF59®, ALVAC-HIV (vCP2438) Placebo)

Completed
Has Results
  • HIV Infection
  • ALVAC-HIV
  • +3 more
  • Durban, KwaZulu-Natal, South Africa
  • +4 more
Nov 3, 2021

HIV Trial in United States (rgp120/HIV-1MN, Zidovudine)

Completed
  • HIV Infections
  • Los Angeles, California
  • +9 more
Oct 27, 2021

COVID-19 Vaccine Trial in Argentina (Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine,

Recruiting
  • COVID-19 Vaccine
  • Gamma Variant RBD-based ARVAC-CG vaccine
  • +3 more
  • Argentina, C.a.b.a., Argentina
    Centro de Educación Médica e Investigaciones Clínicas "Norberto
Feb 28, 2023

HIV Trial in Saint Louis (gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • gp160 Vaccine (MicroGeneSys)
  • Saint Louis, Missouri
    St. Louis Univ. School of Medicine AVEG
Oct 27, 2021

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 26, 2021

HIV Trial in Saint Louis, Rochester, Seattle (Aluminum hydroxide, Lipid A, Monophosphoryl, Lipid A, Liposome-encapsulated

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +7 more
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012

Completed
  • HPV
  • HPV-Related Cervical Carcinoma
  • HPV Vaccine Acceptance Survey
  • (no location specified)
Mar 1, 2023

HIV Trial (DNA Nat-B env vaccine, NYVAC Nat-B env vaccine, DNA CON-S env vaccine)

Withdrawn
  • HIV Infections
  • DNA Nat-B env vaccine
  • +7 more
  • (no location specified)
Oct 13, 2021

AIDS, HIV Trial in San Diego (Fluarix, Pneumovax, Placebo)

Completed
Has Results
  • AIDS
  • HIV
  • Fluarix
  • +2 more
  • San Diego, California
    UCSD Antiviral Research Center (AVRC)
Aug 3, 2022